series-b
Stage
1
Investors
About
Reconnect Labs is a clinical-stage biopharmaceutical company developing precision therapeutics targeting brain and metabolic health, including psychedelic medicines and treatments for psychiatric, sleep, and metabolic disorders.
Explore Reconnect Labs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.